Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Rachel Howard & Parisa Valadan
  • February 27, 2020
  • Webinars

WeChat in China: How pharma and market researchers can utilise this emerging digital platform

WeChat in China: How pharma and market researchers can utilise this emerging digital platform

WeChat is the number one mobile communication platform in China. It has a monthly user base of over 1 billion people and now offers a whole host of features including WeChat pay, mini-programs, social networking and games. In today’s fiercely competitive marketplace, it is critical to keep up with global trends in digital communications. In our last webinar, we looked at the rise of WhatsApp in Latin America. Now we ask, can the WeChat platform be leveraged in China in a similar way, as both a means of collecting insights and ultimately, engaging customers?

read more »

  • Posted by Paul Reed
  • February 24, 2020
  • Videos

Conducting research in Latin America

Paul Reed explores the opportunities in this exciting region, which has diverse and unique healthcare systems, an ageing and declining population, and a rise in the popularity of digital communication channels, especially WhatsApp. 

read more »

How we helped determine the next groundbreaking development in a hard-to-treat respiratory disease

How we helped determine the next groundbreaking development in a hard-to-treat respiratory disease

Our client wanted to understand the current management in a complex therapy area, as treatment regimens require a combination of multiple drugs. Furthermore, the disease is most prevalent in emerging, hard-to-access markets. Understanding of drugs and treatment regimen preferences were required to help gauge likely success of the client’s new formulation in development, which would be part of a new regimen paradigm. As well as understanding current preferences and reactions to the new drug and regimen, the research needed to test several potential outcomes for the new formulation and assess performance against future new regimens likely to be available at the time of launch.

read more »

How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa

How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa

Our client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio. To achieve this, we needed to conduct an in-depth exploration of attitudes and behaviours of people living with HIV. However, stigma surrounding HIV in South Africa meant that respondents may have been unwilling to participate in a traditional interview. Even if they did, it was felt unlikely they would be open to direct questioning. We needed a different approach if we wanted to build a complete picture of life with HIV for our client.

read more »

  • Posted by Rachel Howard
  • December 18, 2019
  • Articles

How were the teenies? Reflecting on global healthcare and market research over the last decade

How were the teenies? Reflecting on global healthcare and market research over the last decade

Back in 2010, I presented my perspective on what the 2010s might look like for healthcare market research and business intelligence at the BHBIA Winter Seminar. As we round out the decade, I thought it would be timely to revisit my predictions and consider which of them actually came to fruition over the last decade, which did not, and why. My first reaction, looking back over my (already horrifyingly dated looking) PowerPoint slides, was to cringe at the nickname I’d assigned to the coming years – “the teenies”. Much like “the noughties” before them, that never caught on. Fortunately, from that point on, the rest of my predictions proved a little more prescient – “on the right track, but a little wide of the mark” is how one of my colleagues summarised them. 

read more »